• OPEN AN ACCOUNT
Indian Indices
Sensex
83,313.93 -503.76
( -0.60%)
Global Indices
Nasdaq
49,515.77 253.77
(0.52%)
Dow Jones
6,903.45 -35.36
(-0.51%)
Hang Seng
53,872.74 -420.62
(-0.77%)
Nikkei 225
10,444.71 130.12
(1.26%)
Forex
USD-INR
90.33 0.00
(0.00%)
EUR-INR
106.65 0.00
(0.00%)
GBP-INR
123.60 0.00
(0.00%)
JPY-INR
0.58 0.00
(0.00%)

EQUITY - MARKET SCREENER

Vanta Bioscience Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
540729
INE695X01011
29.7150858
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
13.87
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

yaari digital integrated services ltd
V-Mart rallies after strong Q2 business update
Oct 03,2025
Revenue from operations stood at Rs 807 crore in Q2 FY26, up 22% year-on-year from Rs 661 crore in the same quarter last year. The company also reported same-store sales growth (SSSG) of 11%, driven equally by its flagship V-Mart and Unlimited formats.

Store expansion remained aggressive, with 25 new outlets added and 2 closed, taking the total store count to 533 as of 30 September 2025. New launches were spread across multiple states, including Karnataka, Uttar Pradesh, Bihar, West Bengal, Jharkhand, and others, underlining the retailer’s focus on tier-2 and tier-3 markets.

V-Mart operates a chain of value retail stores across multiple Indian cities. On a standalone basis, its Q1 FY26 net profit jumped 177% YoY to Rs 33.6 crore, while revenue rose 13% to Rs 885.2 crore.